Globe Life Inc (GL) stock analysis

Globe Life Inc (GL) clears 5 of this site's 8 mechanical value filters, 8 of 8 Buffett-style checks and 4 of 5 Lynch-style checks. A free-cash-flow DCF does not fit insurance companies, so no margin of safety is shown. It returns +7.1% to shareholders net of dilution. Figures are as of October 23, 2026, from SEC filings and market data refreshed weekly; this is educational analysis, not investment advice.

Data as of October 23, 2026. Refreshed weekly from SEC filings and market data.

What does Globe Life do?

Globe Life sells life and supplemental health insurance to middle-income families, often through direct mail and agents.

What stands out about Globe Life?

  • Misses 1 of the 8 value filters. It fails Market Cap > $25B ($12.8B); the other 5 pass and 2 were not evaluated. See every filter.
  • Strongest against peers: net margin. At 19.6% (peer median 14.2%) it ranks 5th of 23 among insurance stocks this site tracks. See the ranking.
  • Weakest against peers: dividend yield. At 0.71% (peer median 1.75%) it ranks 21st of 23 among insurance stocks this site tracks. See the ranking.
  • Returns 7.1% of its value to owners a year. Dividends plus buybacks, minus the stock issued to staff, as a share of market value. See Shareholder Yield Leaders.
GL Globe Life Inc
$168.41
5/8 filtersBuffett 8/8Lynch 4/5Click any figure for its source

How has Globe Life's share price moved?

The interactive price chart needs JavaScript.

Is Globe Life undervalued? The value diligence check

Every value-investing signal this site computes for this stock, gathered in one place: the same real numbers from the tools below, not a new score.

  • Margin of safety (DCF) n/a (Insurance)
  • P/E vs. its own history 10.6x · near the cheap end Real range: 9.3x–13.3x over 5 years (net income per diluted share from each fiscal year's 10-K, paired with the real closing price at that fiscal year-end).
  • Wall St. analyst rating Buy · 3.91/5 23 analysts this month: 4 strong buy, 13 buy, 6 hold, 0 sell, 0 strong sell (Finnhub). Down from 3.96 last month.
  • Altman Z″-Score (bankruptcy risk) n/a (Insurance)
  • Earnings quality (is the profit real?) n/a (bank, insurer or REIT)
  • Shareholder yield (cash back to owners) +7.1% net Latest fiscal year (2025): dividends 0.7% + buybacks 6.9% − stock comp 0.4%, as a share of today's market cap. Over 14 years its split-adjusted share count fell 50%. See Shareholder Yield Leaders.
  • Capital needed to grow (See's test) n/a (bank, insurer, lender or REIT)
  • PEG (growth at a reasonable price) 1.37 · Above fair P/E 10.6× ÷ 7.7% a year of growth behind it. 144th lowest of 447 stocks with a usable PEG. Lynch's fair value is a PEG of 1; a very high PEG usually means almost no growth, a very low one a profit spike. See PEG Ratio Ranking.
  • Compounder lenses (4) 2 of 4 · misses capital-light (n/a), real profit (n/a) Capital-light growth: cannot be measured (bank, insurer, lender or REIT); Profit is real: cannot be measured (bank, insurer or REIT); Cash to owners: cleared; Fair price (PEG): cleared. See Compounders at a Fair Price, which also lets you move the PEG bar.
  • Munger's Inversion Check 0 flags
  • Standing vs. sector peers 3 of 4 measures above the median Compared with the 22 other insurance stocks this site tracks: 2 in the top third, 1 in the bottom third.
  • Dividend payout sustainability 0/6 · clean

How does Globe Life compare with its peers?

3 of 4 measures sit above the median of the 22 other insurance stocks tracked here, 2 in the top third and 1 in the bottom third.

  • P/E ratiolower is cheaper · peer median 13.2× 10.6× 8th of 23
  • Return on equityhigher is better · peer median 20% 20% 9th of 23
  • Net marginhigher is better · peer median 14.2% 19.6% 5th of 23
  • Dividend yieldamong dividend payers · peer median 1.75% 0.71% 21st of 23

Peers are the stocks this site tracks in the same sector group, not every listed competitor. The bar runs from the weakest peer (left) to the strongest (right); the tick is the middle. Measures that don't apply to a sector (cash-flow yield for banks, debt for financials) are left out.

What would Buffett & Lynch say?

Warren Buffett ✓ Leans yes (8/8)

Buffett's checklist is built around durable, profitable businesses bought at sensible prices, and GL clears it. In its favor: GL is currently earning a strong return on shareholders' equity, and has kept that profitability up over five years, not just this year, carries a conservative amount of debt relative to equity, converts sales into profit at healthy margins, has grown earnings per share at a solid clip over five years, earns many times its interest expense, so debt service isn't a worry, is trading below what a conservative discounted-cash-flow estimate says it's worth - his own "price is what you pay, value is what you get" test, not a fixed multiple ceiling, and trades at a reasonable multiple of owner earnings, his own term for the real cash a business could pay out.

  • ROE (TTM) > 11% ✓
  • ROE (5yr avg) > 11% ✓
  • Debt/Equity < 0.5 ✓
  • Pretax margin > 15% ✓
  • EPS growth (5yr) > 7% ✓
  • Interest coverage > 5x ✓
  • Trading below intrinsic value (DCF) ✓
  • Price vs. owner earnings < 25x ✓
  • Bonus: returning capital via buybacks FY2025
Peter Lynch ✕ Leans no (4/5) · Fast Grower

Lynch looked for growth stories that weren't overpriced for that growth, and GL falls short of his bar. In its favor: GL is growing earnings 20-50% a year, his classic fast-grower zone, isn't leaning on debt to fund that growth, isn't asking too much even by a fast grower's usual richer multiple, and is generating real cash to back up a fast grower's higher price tag. Where it comes up short: GL doesn't clear the tighter PEG bar a fast grower needs to justify its pace.

  • PEG < 1 (stricter for fast growers) ✕
  • EPS growth 20%-50% ✓
  • Debt/Equity < 0.5 ✓
  • P/E < 40 ✓
  • Price/FCF < 40 ✓

Quantitative approximations of each investor's documented approach, not endorsed by either investor or their estates - commentary, not this site's actual ranking criteria. Buffett never published a numeric checklist: only 2 of his 8 checks here trace to his own documented concepts ("owner earnings," from his 1986 shareholder letter, and "price is what you pay, value is what you get," his case against fixed P/E/P/B ceilings) - the other 6 (ROE, debt, margins, growth, interest coverage) use commonly-cited thresholds that are not numbers he himself published. The 8 hard filters below (plus the Munger check and Graham margin of safety) are this site's real, mechanical screen and are computed completely independently of the checklists above.

Which of the 8 value filters does Globe Life pass?

  • Market Cap > $25B $12.8B
  • Trailing P/E < 25 10.57
  • PEG Ratio < 1.5 1.37
  • Price/Book < 8 2.08
  • Price/Sales < 7 2.07
  • EPS Growth YoY > -5% +19.4%
  • vs 50-day MA (±12%) Not evaluated †
  • vs 200-day MA (±12%) Not evaluated †

What is Globe Life's margin of safety?

Not applicable (Insurance)

A standard free-cash-flow DCF doesn't fit how insurance companies report cash flow.

Where is Globe Life in its 52-week range?

52w low $130.37 Now $168.41 52w high $186.02

What is the short interest in Globe Life?

% of Float 2.8%
Days to Cover 4.5
vs Prior Period +3.7%

2,142,165 shares short as of 2026-09-30 (FINRA settlement date). Reported twice a month, so this only changes roughly every two weeks, not daily.

What could go wrong with Globe Life? Munger's inversion check

"Invert, always invert." Instead of reasons to buy, these are reasons to hesitate, not a verdict, and not everything worth knowing about a business.

  • Margin of safety, even in the bull case n/a (Insurance)
  • Short interest under 5% of float 2.8%
  • Passes most of the 6 fundamental filters 5/6 passed

Doesn't cover circle of competence, management quality, or accounting concerns: those need judgment, not data.

How much have Globe Life shareholders gained per year?

+16.3%· in USD

Earnings growth per share plus dividend.

Earnings per share, growth per year +15.6%
Dividend (yield on the price) 0.7%
Pace: 5yr vs 9yr 16% vs 14%, accelerating
Profit margin, 2016 to 2025 14% → 19%

An earnings-based proxy, not a stock-price total return - it doesn't capture multiple expansion/contraction or reinvested dividends. EPS from GL's own 10-K filings; dividend yield is the current trailing yield on today's price, from the same weekly fetch as the rest of this site.

What do Globe Life's 10-year financials show?

From GL's own 10-K filings (SEC EDGAR): up to the last 10 fiscal years. Press any year's bars for the exact figures.

Revenue Net income
$0 $2.0B $4.0B $6.0B 2016 revenue: $3.9B 2016 net income: $550.0M '16 2017 revenue: $4.2B 2017 net income: $1.5B '17 2018 revenue: $4.3B 2018 net income: $701.0M '18 2019 revenue: $4.5B 2019 net income: $761.0M '19 2020 revenue: $4.7B 2020 net income: $732.0M '20 2021 revenue: $5.1B 2021 net income: $1.0B '21 2022 revenue: $5.2B 2022 net income: $894.0M '22 2023 revenue: $5.4B 2023 net income: $971.0M '23 2024 revenue: $5.8B 2024 net income: $1.1B '24 2025 revenue: $6.0B 2025 net income: $1.2B '25
Debt/Equity (2025) 0.39 10yr trend: 0.25 → 0.39
Open in Technical Analysis → Open in Intrinsic Value Calculator → Educational content only, not investment advice.

Frequently asked questions about Globe Life

What kind of company is Globe Life?

Globe Life sells life and supplemental health insurance to middle-income families, often through direct mail and agents. This site groups it with Insurance stocks.

Why does Globe Life have no margin of safety on this site?

This site's DCF values a company from its free cash flow, and that does not fit insurers, whose operating cash flow swings with premiums, claims and investment float rather than with what is left over for owners. So GL gets no margin of safety; judge it on the other checks on this page, such as its filters, shareholder yield and ranking against its peers. The method is in the Intrinsic Value Calculator.

How many of this site's 8 value filters does Globe Life pass?

GL passes 5 of 8. It passes Trailing P/E < 25 (10.57), PEG Ratio < 1.5 (1.37), Price/Book < 8 (2.08), Price/Sales < 7 (2.07) and EPS Growth YoY > -5% (+19.4%). It misses Market Cap > $25B ($12.8B). vs 50-day MA (±12%) and vs 200-day MA (±12%) were not evaluated, because the moving-average checks only run on stocks that clear the fundamentals first. The 8-filter list shows every stock that passes all of them.

Does Globe Life pass the Buffett-style and Lynch-style checklists?

On this site's Buffett-style checklist GL clears 8 of 8 checks and leans yes. On the Lynch-style checklist it clears 4 of 5 and leans no, with Fast Grower as its Lynch category; it misses PEG < 1 (stricter for fast growers). These are this site's own rules written in the style of each investor, not their personal views; the rules are in the Editorial Standards.

How much cash does Globe Life return to shareholders?

GL's net shareholder yield is +7.1%: the cash it returns through dividends and buybacks, minus stock-based compensation, as a share of its market value. Latest fiscal year (2025): dividends 0.7% + buybacks 6.9% − stock comp 0.4%, as a share of today's market cap. Over 14 years its split-adjusted share count fell 50%. Its trailing dividend yield is 0.71%, paid out of 7% of its free cash flow; the dividend-sustainability check raises 0 of 6 flags. See Shareholder Yield Leaders and the Sustainable Dividend Screener.

How fast has Globe Life grown its revenue and profit?

From fiscal 2016 to fiscal 2025, GL's revenue grew from $3.9 billion to $6.0 billion, 4.8% a year. Net income went from $550 million to $1.2 billion, and its net profit margin from 14.0% to 19.4%. Earnings per share went from $4.49 to $14.08 on today's share count, 13.5% a year. All figures are from GL's own 10-K filings (SEC EDGAR) and are shown year by year in the 10-Year Financials section of the card above.

Where do these numbers come from?

About this Globe Life Inc analysis

This page shows every value-investing check the site runs on Globe Life Inc (GL) in one place: the 8 mechanical filters, the Buffett and Lynch checklists, a margin of safety from a disclosed DCF, earnings quality, shareholder yield and how it ranks against its sector peers. The numbers come from SEC filings and public market data, refreshed weekly, and the same rules apply to every stock on the stock list. See Editorial Standards for the sources and the rules, or run your own filters in the stock screener.